Catalent ($CTLT) $78M Investor Settlement
Catalent ($CTLT) has agreed to settle $78 million with investors to resolve claims that it overstated customer demand and financial guidance, and concealed serious production issues.
Catalent presented itself as a key COVID-19 vaccine supplier and assured investors that demand remained strong. However, from late 2022 through 2023, the company disclosed serious manufacturing issues, elevated inventory levels, and weaknesses in internal controls. The company’s stock declined by more than 70%, leading to investor losses and a shareholder lawsuit.
Between August 2021 and November 2023: Catalent assured investors that its operations were running efficiently and its financial outlook remained strong.
On November 1, 2022: Catalent reduced FY23 guidance citing “macro” issues, and the stock dropped 30%.
On February 24, 2023: Investors filed a class action lawsuit against Catalent.
On April 14, 2023: The company revealed productivity challenges and inventory mismanagement. $CTLT fell another 26%.
On December 29, 2025: Catalent agreed to a $78M settlement to resolve all claims.
Catalent is a global drug manufacturer that gained attention during the COVID-19 pandemic for its role in vaccine production.
From August 2021 through May 2023, Catalent’s leadership told investors that demand remained strong and that manufacturing capacity was being used at near-peak levels.
In the Q2 2022 earnings call, executives said that “drug product remains in extremely high demand across the board… the pipeline outside of vaccines remains very robust … Catalent has positioned ourselves very well,” pointing to strong demand across the company’s non-COVID business.
Executives also said the company was transitioning from COVID-19 vaccine production to gene therapies and other specialty products to help offset declining pandemic-related revenue.
On November 1, 2022, Catalent reduced its fiscal 2023 guidance, citing macroeconomic conditions. Following the announcement, $CTLT fell by about 30% in one day.
Additional issues were disclosed on April 14, 2023. Catalent reported internal operational problems and higher-than-expected costs at multiple facilities, including its Harmans, Bloomington and Brussels sites. The company said these challenges would affect its third-quarter results and outlook for the full fiscal year.
Following this disclosure, the stock declined by another 26%.
After these disclosures, investors filed a lawsuit, claiming the company misrepresented its operations and withheld information about internal issues.
Catalent ($CTLT) has agreed to settle $78 million with investors to resolve claims that it overstated customer demand and financial guidance and concealed serious production issues.
If you were damaged due to this situation, you can file for a payout and get your share of the settlement.
Frequently Asked Questions
all persons and entities who or which, during the period from August 30, 2021, through May 7, 2023, inclusive, purchased or otherwise acquired the publicly traded common stock or exchange-traded call options or sold the exchange-traded put options of Catalent, and were allegedly damaged thereby
No, if you have purchased securities within the class period, you are eligible to participate.
You can participate in the settlement and retain (or sell) your securities.
The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
The final payout amount depends on your specific trades and the number of investors participating in the settlement.
If 100% of investors file their claims - the average payout will be $0.61 per share. Although typically only 25% of investors file claims, in this case, the average recovery will be $2.44 per share.
If you're eligible, you can file your claim directly from this case page by clicking the "Collect Payout" button.
More than 100 companies are currently paying out settlements. Connect your brokerage account to automatically check which ones you may have missed — or file manually for this case.
11th.com is an investor recovery company that helps investors track and collect securities class action settlements. We will:
1. Prepare documents for your payout.
2. Audit the claim and make sure you get the maximum possible payout.
3. File a claim with the settlement administration.
4. Correspond with the settlement administration to resolve emerging issues.
5. Deliver payout directly to your brokerage account.
There is no upfront cost, but we will deduct 20% of the recovered amount as a commission for our services.